Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months
Crossref DOI link: https://doi.org/10.1186/s13601-017-0143-1
Published Online: 2017-03-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Riccio, Anna Maria
Mauri, Pierluigi
De Ferrari, Laura
Rossi, Rossana
Di Silvestre, Dario
Benazzi, Louise
Chiappori, Alessandra
Dal Negro, Roberto Walter
Micheletto, Claudio
Canonica, Giorgio Walter